Persistent URL of this record https://hdl.handle.net/1887/118269
In Collections
This item can be found in the following collections:
Low Incidence of Post-Transplant EBV-Related Disease After Alemtuzumab-Mediated T Cell Depletion Is Explained by the Differential Susceptibility to Alemtuzumab of B Cells and Protective CD8 and CD4 T Cells
- All authors
- Halkes, C.J.M.; Jedema, I.; Wolbers, J.O.; Egmond, E.M. van; Borne, P.A. von dem; Marijt, E.W.A.F.; Falkenburg, J.H.F.
- Date
- 2010-11-19
- Title of host publication
- Blood
- Volume
- 116
- Issue
- 21
- Pages
- 962 - 963